Kos Biotechnology Partners Raises $123M for Inaugural Greek Life Sciences Fund

Deal Summary

Kos Biotechnology Partners announced the third closing of its inaugural global life sciences fund, raising $123 million, the first dedicated biotech fund in Greece. Backed by the Hellenic Development Bank of Investments and global family offices, the fund will invest from company formation to Series C in novel therapeutics, pharma services and technology‑enabled platforms. Additional investments are expected later this year.